Contact
Please use this form to send email to PR contact of this press release:
Rapafusyn Pharmaceuticals Secures $28 Million Series A to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform
TO:
Please use this form to send email to PR contact of this press release:
Rapafusyn Pharmaceuticals Secures $28 Million Series A to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform
TO: